Research Paper Volume 16, Issue 2 pp 1021—1048
Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer
Figure 1. Different expression of TFAP2A. (A) Different Expression of TFAP2A. (A) Differential TFAP2A mRNA expression between unpaired TCGA cancers and GTEX normal tissues; Red columns: cancer samples; Blue columns: normal samples; (B) The TFAP2A mRNA expression in 33 cancer types from TIMER database; (C) TFAP2A mRNA expression in different cancer cell lines from CCLE database; *p < 0.05, **p < 0.01, and ***p < 0.001.